Microbiologists Argue Threat to Future

ATLANTA—Are academic microbiology departments suffering from the increased attention being paid to molecular biology and related disciplines? Scientists at the recent annual meeting of the American Society for Microbiology here could not agree if the issue was simply a semantic argument or a symptom of a genuine crisis. "A number of forces are converging to create a problem … and together they may deal us a blow that could be lethal" to the future of microbiology, suggested M. Michae

Written byTheresa Waldron
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

"A number of forces are converging to create a problem … and together they may deal us a blow that could be lethal" to the future of microbiology, suggested M. Michael Sigel, chairman of the department of microbiology and immunology at the University of South Carolina. Sigel lamented the lack of "momentum, interest, commitment, people and funding" in microbiology departments at medical schools and universities nationwide, and said departments were "losing their identities" to other fields in biology.

But Richard A. Finkeistein, chairman of the microbiology department at the University of Missouri School of Medicine, claimed that the evidence for such a problem is suspect. "Two or three people have noticed that a half dozen departments of microbiology have changed their names or been merged with other departments in the last couple of years," he noted. "I'd hardly call that a trend [showing] that microbiology departments are dying."

But Sigel ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies